CVS Health (CVS) PT Raised to $101 at Piper Sandler as 'CY25 Execution Builds Trust'
Tweet Send to a Friend
Piper Sandler analyst Jessica Tassan raised the price target on CVS Health (NYSE: CVS) to $101.00 (from $99.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
